StockData
Enovis CORP logo

Enovis CORP (ENOV) stock

ENOVNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3066% below fair value
$27.10−0.12 (-0.44%)

Close on Nov 18, 2026Market cap $1.56BP/E –Yield –

Enovis pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Enovis's pe ratio was 149.9× on Jan 31, 2023, against 56.8× a year earlier. Over the last 5 years it ranged from 21.5× to 149.9×, with a median of 35.3×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2023Jan 31, 2023149.9×+22.4
2022Dec 30, 2022127.4×+63.9
2021Dec 31, 202163.6×+15.0
2019Jul 31, 201948.6×+24.8
2018Dec 31, 201823.8×−4.2
2017Dec 29, 201727.9×+1.1
2016Dec 30, 201626.8×+15.5
2015Dec 31, 201511.3×−8.2
2014Dec 31, 201419.5×−28.1
2013Dec 31, 201347.5×−291.4
2012Apr 30, 2012338.9×+296.5
2011Dec 30, 201142.4×–

More Enovis figures

See a number that looks wrong?